Literature DB >> 16495282

Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.

Glenn A Pankuch1, Peter C Appelbaum.   

Abstract

Agar dilution was used, and MICs of metronidazole, tizoxanide, nitazoxanide, denitrotizoxanide, RM 4803, RM 4807, RM 4809, RM 4819, amoxicillin-clavulanate, and clindamycin were measured against 412 anaerobes. Nitazoxanide, tizoxanide, RM 4807, and RM 4809 were active against all groups, except for gram-positive non-spore-forming rods with 50% minimum inhibitory concentrations (when the latter were excluded) of 1 to 2 microg/ml and 90% minimum inhibitory concentrations of 4 to 8 microg/ml, respectively. Metronidazole MICs were usually lower against all groups except clostridia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495282      PMCID: PMC1426457          DOI: 10.1128/AAC.50.3.1112-1117.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Nitazoxanide As Treatment of Intestinal Parasites in Children.

Authors:  Richard D. Pearson
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 2.  Diarrhea in developed and developing countries: magnitude, special settings, and etiologies.

Authors:  R L Guerrant; J M Hughes; N L Lima; J Crane
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

3.  Nitazoxanide: a new thiazolide antiparasitic agent.

Authors:  LeAnne M Fox; Louis D Saravolatz
Journal:  Clin Infect Dis       Date:  2005-03-14       Impact factor: 9.079

4.  In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Authors:  L Dubreuil; I Houcke; Y Mouton; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

6.  Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.

Authors:  Lois M Ednie; Ashok Rattan; Michael R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

7.  Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.

Authors:  Yvonne Guttner; Helen M Windsor; Charlie H Viiala; Leon Dusci; Barry J Marshall
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 8.  Antibiotic-associated diarrhea.

Authors:  J G Bartlett
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

  8 in total
  24 in total

1.  Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity.

Authors:  T Eric Ballard; Xia Wang; Igor Olekhnovich; Taylor Koerner; Craig Seymour; Joseph Salamoun; Michelle Warthan; Paul S Hoffman; Timothy L Macdonald
Journal:  ChemMedChem       Date:  2010-12-29       Impact factor: 3.466

2.  Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.

Authors:  T Eric Ballard; Xia Wang; Igor Olekhnovich; Taylor Koerner; Craig Seymour; Paul S Hoffman; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2010-05-18       Impact factor: 2.823

3.  Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.

Authors:  P Ripani; J Delp; K Bode; M E Delgado; L Dietrich; V M Betzler; N Yan; G von Scheven; T U Mayer; M Leist; T Brunner
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

4.  In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.

Authors:  Laura V Ashton; Robert L Callan; Sangeeta Rao; Gabriele A Landolt
Journal:  Vet Med Int       Date:  2010-08-12

5.  Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).

Authors:  Gilles Gargala; Arnaud François; Loïc Favennec; Jean-François Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

6.  Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria.

Authors:  Andrew J Kennedy; Alexandra M Bruce; Catherine Gineste; T Eric Ballard; Igor N Olekhnovich; Timothy L Macdonald; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 7.  Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

Authors:  Vanessa R Anderson; Monique P Curran
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

9.  Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.

Authors:  Paul S Hoffman; Alexandra M Bruce; Igor Olekhnovich; Cirle A Warren; Stacey L Burgess; Raquel Hontecillas; Monica Viladomiu; Josep Bassaganya-Riera; Richard L Guerrant; Timothy L Macdonald
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

10.  In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.

Authors:  David W Hecht; Minerva A Galang; Susan P Sambol; James R Osmolski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.